Log In
BCIQ
Print this Print this
 

triple-bead MAS (SHP465) (formerly SPD465)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionThree-component, extended-release, single-entity mixed amphetamine salts (MAS)
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD
Regulatory Designation U.S. - Standard Review (Treat ADHD)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today